Fas expression in primary breast cancer is related to neoplastic infiltration of perilymphatic fat
Authors:
- M BębenekMBM Bębenek
- D DuśDDD Duś
- J KoźlakJKJ Koźlak
- 1 January 2008
- journal article
- Published by Elsevier in Advances in Medical Sciences
- Vol. 53 (1) , 49-53
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Altered Expression of FAS System Is Related to Adverse Clinical Outcome in Stage I-II Breast Cancer Patients Treated with Adjuvant Anthracycline-Based ChemotherapyClinical Cancer Research, 2004
- Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligandCancer Chemotherapy and Pharmacology, 2003
- Fas (CD95/APO‐1) and Fas ligand expression in normal pancreas and pancreatic tumorsCancer, 2002
- Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cellsBritish Journal of Cancer, 2000
- Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breastThe Journal of Pathology, 2000
- Prognostic relevance of altered Fas (CD95)-system in human breast cancerInternational Journal of Cancer, 2000
- Expression of Fas ligand in liver metastases of human colonic adenocarcinomasProceedings of the National Academy of Sciences, 1997
- The Fas Death FactorScience, 1995
- Expression of APO‐1 (CD95), a member of the NGF/TNF receptor superfamily, in normal and neoplastic colon epitheliumInternational Journal of Cancer, 1994
- Paranodal tumour in breast cancer: Extranodal extension versus vascular spreadThe Journal of Pathology, 1984